快速微型生物系统首席执行官和主任购买股份,尽管股票回报负。 Rapid Micro Biosystems CEO and Director purchase shares, despite negative return on equity.
快速微型生物系统首席执行官Robert G. Spignesi和Richard S. Kallender董事,两人最近都在公司购买了股份。 Rapid Micro Biosystems CEO, Robert G. Spignesi, and Director, Richard S. Kollender, both recently bought shares in the company. 8月6日,Kallender在7.77/share购买了65 000股股票,将他的股票总所有权提高到96 718股。 Kollender purchased 65,000 shares at $0.77/share on August 6th, raising his total stock ownership to 96,718 shares. Spignesi以同样价格购买了50 000股股票,将直接持有的股票增加到540 012股。 Spignesi bought 50,000 shares at the same price, increasing his direct holdings to 540,012 shares. 尽管购买了股份,但该公司报告说,8月2日截止的季度股票收益为45.23%,净利润为204.22%。 Despite the share purchases, the company reported a negative return on equity of 45.23% and a net margin of -204.22% for the quarter ending August 2nd. 快速微生物系统开发出用于检测药物、医疗装置和个人护理产品制造中的微生物污染的产品。 Rapid Micro Biosystems develops products for detecting microbial contamination in pharmaceutical, medical device, and personal care product manufacturing.